GAPVAC at the EANO conference (Oct 10-14) in Stockholm, Sweden

| News, USA

Prof. Pierre-Yves Dietrich, Co-lead Investigator of the GAPVAC-101 trial and Director of the Centre of Oncology at the Geneva University Hospital, to present results from the GAPVAC trial at EANO conference (Oct 10-14) in Stockholm:


October 12, 11:27am-11:39am

Oral Session 2: Non-surgical treatment (Room: A2)

"Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial"


We're looking forward to interesting and exciting discussions.

Further information on EANO here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.